A. Kabral
- Hematology top 2%
- Acute Myeloid Leukemia Research 9
- Hematopoietic Stem Cell Transplantation 7
- Platelet Disorders and Treatments 3
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research 4
-
- Acute Lymphoblastic Leukemia research 11
-
- Glycosylation and Glycoproteins Research 4
-
- CAR-T cell therapy research 4
-
- Monoclonal and Polyclonal Antibodies Research 4
A. Kabral
26 papers receiving 590 citations
Peers
Comparison fields: 5 of 56
- Hematology 443
- Immunology and Allergy 79
- Genetics 76
- Immunology 132
- Public Health, Environmental and Occupational Health 135
Countries citing papers authored by A. Kabral
This map shows the geographic impact of A. Kabral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Kabral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Kabral more than expected).
Fields of papers citing papers by A. Kabral
This network shows the impact of papers produced by A. Kabral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Kabral. The network helps show where A. Kabral may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A. Kabral, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 6 | |
| 2 | 1991 | 14 | |
| 3 | 1990 | 10 | |
| 4 | 1990 | 1 | |
| 5 | 1989 | 1 | |
| 6 | 1989 | 30 | |
| 7 | 1989 | 75 | |
| 8 | 1989 | 2 | |
| 9 | Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia. | 1989 | 10 |
| 10 | 1988 | 23 | |
| 11 | 1988 | 30 | |
| 12 | 1988 | 38 | |
| 13 | 1987 | 7 | |
| 14 | Characterization of monoclonal antibodies to the human myeloid-differentiation antigen, 'gp67' (CD-33). | 1987 | 10 |
| 15 | 1986 | 16 | |
| 16 | 1986 | 18 | |
| 17 | 1985 | 20 | |
| 18 | 1985 | 196 | |
| 19 | 1985 | 13 | |
| 20 | 1983 | 24 |
About A. Kabral
A. Kabral is a scholar working on Hematology, Immunology and Allergy, Public Health, Environmental and Occupational Health, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 26 papers that have together received 610 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (9 papers), Hematopoietic Stem Cell Transplantation (7 papers), Glycosylation and Glycoproteins Research (4 papers), CAR-T cell therapy research (4 papers), Cell Adhesion Molecules Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Platelet Disorders and Treatments (3 papers). The work is most often cited by research in Hematology (443 citations), Immunology and Allergy (79 citations), Genetics (76 citations), Immunology (132 citations) and Public Health, Environmental and Occupational Health (135 citations). A. Kabral has collaborated with scholars based in Australia, Thailand and France. Frequent co-authors include Kenneth F. Bradstock, Michael C. Berndt, Heddy Zola, Dominique J. Fournier, P.A. Castaldi, Cheryl Y. Gregory, W. G. Hughes, Philip Grimsley, Emmanuel J. Favaloro and V Makrynikola. Their work appears in journals such as British Journal of Haematology, Leukemia Research, Pathology, Blood and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.